Infographic titled "From Lab To Life: How Diabetes Rewires the Peripheral Nervous System – And what that means for treatment?" It is divided into four sections. The first section, "The Challenge," explains that about 50% of diabetes patients develop diabetic peripheral neuropathy (DPN), which causes pain, numbness, and disability, and highlights the lack of understanding of nerve degeneration. The second section, "What they did?" describes how researchers collected human tibial and sural nerves and used spatial transcriptomics to map gene activity and track inflammation and mRNA transport. The third section, "What they found?" reports increased inflammation markers (IL6, IL1B, CXCL2) and fibrosis markers (TGF-B, Tenascin) in DPN nerves. The final section, "Why it matters?" emphasizes the potential for early intervention to prevent fibrosis and axonal loss, moving toward personalized care. Visuals include a leg with pain indicators and a nerve illustration showing inflammation. The study is credited to Tavares-Ferreira et al., J Clin Invest, 2025, with a DOI link.
🧠From Lab To Life
Why do peripheral nerves suffer axonal loss in diabetes?
A study led by @dianatavf.bsky.social from the @tedpricethepainguy.bsky.social lab showed how inflammation leads to neural fibrosis in diabetic peripheral neuropathy! #PainResearch #Neuroskyence #FromLabToLife 1/